144 related articles for article (PubMed ID: 28088523)
1. The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling.
Peng J; Zhou H; Kuang G; Xie L; Tian T; Liu R
Biochem Biophys Res Commun; 2017 Mar; 484(3):474-479. PubMed ID: 28088523
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts.
Liu Y; Kimura K; Orita T; Suzuki K; Teranishi S; Mori T; Sonoda KH
Mol Vis; 2015; 21():1368-77. PubMed ID: 26788029
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):995-1001. PubMed ID: 29032198
[TBL] [Abstract][Full Text] [Related]
4. Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix.
Guan T; Zhao G; Duan H; Liu Y; Zhao F
Biomed Pharmacother; 2017 Nov; 95():1704-1709. PubMed ID: 28958132
[TBL] [Abstract][Full Text] [Related]
5. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
6. The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Int Immunopharmacol; 2018 Feb; 55():193-197. PubMed ID: 29268191
[TBL] [Abstract][Full Text] [Related]
7. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by all-trans-retinoic acid of transforming growth factor-β-induced collagen gel contraction mediated by human tenon fibroblasts.
Liu Y; Kimura K; Orita T; Teranishi S; Suzuki K; Sonoda KH
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4199-205. PubMed ID: 24894398
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta.
Asakura T; Ishii Y; Chibana K; Fukuda T
J Allergy Clin Immunol; 2004 Aug; 114(2):310-5. PubMed ID: 15316508
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid inhibition of transforming growth factor-β-induced collagen gel contraction mediated by human Tenon fibroblasts: role of matrix metalloproteinases.
Liu Y; Kimura K; Orita T; Teranishi S; Suzuki K; Sonoda KH
Br J Ophthalmol; 2015 Apr; 99(4):561-5. PubMed ID: 25614514
[TBL] [Abstract][Full Text] [Related]
11. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
12. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
13. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
14. Effect of cytoglobin overexpression on extracellular matrix component synthesis in human tenon fibroblasts.
Wei H; Lin L; Zhang X; Feng Z; Wang Y; You Y; Wang X; Hou Y
Biol Res; 2019 Apr; 52(1):23. PubMed ID: 30992080
[TBL] [Abstract][Full Text] [Related]
15. Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ.
Wu Y; Cui C; Bi FF; Wu CY; Li JR; Hou YM; Jing ZH; Pan QM; Cao M; Lv LF; Li XL; Shan HL; Zhai X; Zhou YH
Eur J Pharmacol; 2022 May; 923():174892. PubMed ID: 35358494
[TBL] [Abstract][Full Text] [Related]
16. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
18. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
19. Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: role of intracellular signaling molecules.
Liu Y; Ko JA; Yanai R; Kimura K; Chikama T; Sagara T; Nishida T
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1429-36. PubMed ID: 18385060
[TBL] [Abstract][Full Text] [Related]
20. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
